TINIDAZOLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tinidazole, and what generic alternatives are available?
Tinidazole is a drug marketed by Chartwell Rx, Edenbridge Pharms, Hikma, and Thinq Pharm-cro Pvt. and is included in four NDAs.
The generic ingredient in TINIDAZOLE is tinidazole. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the tinidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tinidazole
A generic version of TINIDAZOLE was approved as tinidazole by CHARTWELL RX on April 30th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TINIDAZOLE?
- What are the global sales for TINIDAZOLE?
- What is Average Wholesale Price for TINIDAZOLE?
Summary for TINIDAZOLE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 134 |
| Clinical Trials: | 40 |
| Patent Applications: | 3,915 |
| Drug Prices: | Drug price information for TINIDAZOLE |
| DailyMed Link: | TINIDAZOLE at DailyMed |
See drug prices for TINIDAZOLE
Recent Clinical Trials for TINIDAZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shangrong Fan | N/A |
| Exeltis Turkey | Phase 1 |
| Monitor CRO | Phase 1 |
Pharmacology for TINIDAZOLE
| Drug Class | Nitroimidazole Antimicrobial |
Medical Subject Heading (MeSH) Categories for TINIDAZOLE
Anatomical Therapeutic Chemical (ATC) Classes for TINIDAZOLE
US Patents and Regulatory Information for TINIDAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | TINIDAZOLE | tinidazole | TABLET;ORAL | 202044-001 | Apr 30, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Thinq Pharm-cro Pvt | TINIDAZOLE | tinidazole | TABLET;ORAL | 202489-001 | Oct 9, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Edenbridge Pharms | TINIDAZOLE | tinidazole | TABLET;ORAL | 203808-002 | Aug 4, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Thinq Pharm-cro Pvt | TINIDAZOLE | tinidazole | TABLET;ORAL | 202489-002 | Oct 9, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | TINIDAZOLE | tinidazole | TABLET;ORAL | 202044-002 | Apr 30, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Edenbridge Pharms | TINIDAZOLE | tinidazole | TABLET;ORAL | 203808-001 | Aug 4, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | TINIDAZOLE | tinidazole | TABLET;ORAL | 201172-002 | Apr 30, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
